Expanding National Clinical Outcome Assessment Capacity with Train(e)d

To improve diagnosis, monitor disease progression, and evaluate treatment response, NMD4C’s Outcome Measures and Natural History (OMNH) group is building a national framework for outcome measure development and infrastructure for natural history studies, integrating patient-reported outcome measures, and expand diagnostic imaging capacity.

This work will support clinical trials, real-world evidence generation, and improved care for individuals living with NMDs.

As knowledge gaps in outcome measures assessments have become evident, MDC together with the NMD4C have developed Train(e)d, an on-demand e-learning platform designed to address gaps in evaluator training and improve the consistency of clinical assessments across Canada.

This platform is a part of NMD4C’s goal of developing resources that aim to harmonize outcome measures and promote accessible, sustainable, and validated training, thus increasing clinical capacity on a national level.

Enrollment keys are required to access our course modules. These will be provided by email within the next business day after registering.

NEWS_TRAINED

Read next...

BSTC logo

Call for Applications: Join the NMD4C Basic Science Trainee Committee (BSTC)

We are thrilled to announce that the Applications are now open to Join our Basic Science Trainee Committee (BSTC) The Neuromuscular Disease Network for Canada (NMD4C) is inviting applications for our Basic Science Trainee Committee (BSTC) from trainees who are interested in contributing to national initiatives that support the neuromuscular research, clinical, and trainee communities. We…

BSTC logo

BSTC Launches Standard Operating Procedures (SOPs)

We’re pleased to announce the launch of the BSTC Standard Operating Procedures (SOPs), now available through the NMD4C Resource Hub. These SOPs provide standardized guidance for laboratories, clinics, and research programs across Canada, supporting consistent, high-quality neuromuscular care and research. Explore the full SOP Library and other open-access resources designed to advance collaboration and strengthen practices nationwide.

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Nov 26-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!